Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS.
27 employees · est. 2006 · Covington, United States
Bexion Pharmaceuticals is the older company (2006 vs 2023).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Bexion Pharmaceuticals | CervoMed |
|---|---|---|
| Founded | ||
| Founded | 2006 older | 2023 |
| Headquarters | ||
| Headquarters | Covington, United States | Boston, United States |
| Employees | ||
| Employees | 27 | 20 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $18.00M | $149.40M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Development of cancer therapies, Clinical-stage drug development, Phase 1b/2a clinical trials, Biologic therapy research | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Oncologists, Clinical researchers, Biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncology, CNS (Central Nervous System), S1P Modulator, BXQ-350, Tumor Targeting, Phosphatidylserine Patches, Acid Sphingomyelinase Activation, Ceramide Generation, Caspase Elevation, Biopharmaceutical, Clinical Development, Novel Mechanism Of Action, Tumor Neovasculature, Apoptosis Induction | Biopharmaceuticals, Neurodegenerative Diseases, CNS Therapeutics, R&D, Pharmaceutical Industry, Biotech Industry, Mergers And Acquisitions, Public Companies, Boston, Medical Research, Drug Development, Clinical Trials, Healthcare Innovations |
| Website | ||
| Website | bexionpharma.com | cervomed.com |
About Bexion Pharmaceuticals
Bexion Pharmaceuticals, founded in 2006, is a United States-based company operating at the forefront of the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. The company has carved out a niche in developing transformative treatments within the oncology and central nervous syste...
About CervoMed
CervoMed is a public, Boston, MA-based company that focuses on advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. The company was originally launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry. In August, 2023, EIP...
We will tell you when either one moves
BounceWatch watches Bexion Pharmaceuticals and CervoMed for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bexion Pharmaceuticals and CervoMed — by email.
Frequently Asked Questions
Compare Bexion Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Bexion Pharmaceuticals on 11 Mar 2026, and CervoMed on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
